Measurement of Lung Water by Transpulmonary Thermodilution in Lung Transplanted Patients (PICCO-LungT)

This study has been completed.
Sponsor:
Information provided by:
Hopital Foch
ClinicalTrials.gov Identifier:
NCT00834054
First received: February 2, 2009
Last updated: July 18, 2011
Last verified: July 2011
  Purpose

Repeated measurements of lung water by single transpulmonary thermodilution during the first postoperative days following lung transplantation


Condition Intervention
Mucoviscidosis
Pulmonary Insufficiency
Procedure: Double-lung transplantation

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Interest of Repeated Extravascular Lung Water Measurements With the PICCO Device in Lung Transplanted Patients

Resource links provided by NLM:


Further study details as provided by Hopital Foch:

Primary Outcome Measures:
  • extra-vascular lung water [ Time Frame: first postoperative days ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • pulmonary permeability index [ Time Frame: first postoperative days ] [ Designated as safety issue: No ]

Estimated Enrollment: 15
Study Start Date: January 2009
Study Completion Date: July 2011
Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Double-lung transplanted patients Procedure: Double-lung transplantation
Double-lung transplanted patients

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

double-lung transplanted patients

Criteria

Inclusion Criteria:

  • double-lung transplanted patients

Exclusion Criteria:

  • none
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00834054

Locations
France
Hopital Foch
Suresnes, France, 92150
Sponsors and Collaborators
Hopital Foch
Investigators
Study Chair: Charles Cerf, MD Hopital Foch
  More Information

No publications provided

Responsible Party: Hopital Foch
ClinicalTrials.gov Identifier: NCT00834054     History of Changes
Other Study ID Numbers: 2008/18
Study First Received: February 2, 2009
Last Updated: July 18, 2011
Health Authority: France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Additional relevant MeSH terms:
Cystic Fibrosis
Pancreatic Diseases
Digestive System Diseases
Lung Diseases
Respiratory Tract Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases

ClinicalTrials.gov processed this record on July 23, 2014